With just hours to go for Congress to act, we look at what could be affected if a government shutdown begins this weekend. And it’s the end of an era as Netflix ships out its final DVDs. These stories and more highlight The Morning Rundown for Friday, Sept. 29, 2023. Congress has only hours to act before…

On Tuesday, Sept. 19, the Food and Drug Administration decline to approve Neffy, a nasal spray equivalent of an EpiPen. The first needle-free option to treat severe allergic reactions made by ARS Pharmaceuticals was declined approval as the FDA requested more testing on repeat doses. The decision by the FDA was surprising for the drug…

Lawyers for Hunter Biden have revealed his plans following an indictment on federal gun charges. And, in what is being called a surprise move, the FDA rejects the first nasal spray alternative to EpiPens. These stories and more highlight The Morning Rundown for Wednesday, Sept. 20, 2023. Hunter Biden to plead not guilty on federal gun charges…

The leaders of North Korea and Russia meet as the two U.S. adversaries look to strengthen their relationship. And Apple unveils big changes with its next generation of iPhones. These stories and more highlight the Morning Rundown for Sept. 13, 2023. Kim Jong Un meets with Vladimir Putin in Russia North Korean leader Kim Jong…

The FDA sent warning letters to three baby formula manufacturers regarding their cleaning and sanitizing practices. Each of the companies recalled products in the last year, and the FDA wants to ensure they’re taking steps to prevent it from happening again.  The companies — Reckitt, Perrigo and ByHeart — make Enfamil Prosobee Simply Plant-Based Infant…

Three judges on the 5th U.S. Circuit Court of Appeals in New Orleans backed some limits on the abortion pill Mifepristone. However, the ruling on Wednesday, Aug. 16 cannot take effect until the Supreme Court weighs in. The appeals court ruling partially overturned a lower court ruling that revoked the Food and Drug Administration’s (FDA)…